Article
Hydroxychloroquine as Adjuvant Therapy with Immunotherapy for Prevention of Activation of Latent Tuberculosis: Restoring Interferon-Gamma Competence in Patients Receiving TNF-Alpha Inhibitors
2026-03-17
Abstract excerpt
<h4>Background: </h4> Tumor necrosis factor-alpha (TNF-α) inhibitors have transformed the management of chronic inflammatory diseases, yet they impose a substantially elevated risk of tuberculosis (TB) reactivation—up to 25-fold depending on the agent used. This risk is principally driven by disruption of granuloma architecture and suppression of interferon-gamma (IFN-γ)–dependent macrophage bactericidal activity....
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ffe8af7e-ba14-59e7-b150-7a2cdc3d0c7f
- DOI
- 10.20944/preprints202603.1220.v1
